40.40 (-%)
As of Nov 01, 2024
Source:
Mirum Pharmaceuticals, Inc is a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases. We have three approved medicines: Livmarli, Cholbam, and Chenodal.
Country | United States |
Headquarters | foster city, california |
Phone Number | (650) 667-4085 |
Industry | manufacturing |
CEO | Christopher Peetz |
Website | www.mirumpharma.com |